RECRUITING

Clinical Outcomes and Healthcare Economics of SOLTIVE Compared to Ho:YAG Laser in Urolithiasis

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To compare intraoperative as well as postoperative outcomes of SOLTIVE Thulium laser compared to Ho:YAG laser for the treatment of urolithiasis. The hypothesis is that utilizing the SOLTIVE Thulium laser for the treatment of urolithiasis will result in a more efficient procedure, with comparable stone free rate to that of Holmium laser and subjective improvement in physician satisfaction.

Official Title

Clinical Outcomes and Healthcare Economics of SOLTIVE Compared to Ho:YAG Laser in Urolithiasis

Quick Facts

Study Start:2022-09-01
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04997668

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patients must be 18 years of age or older
  2. 2. Patients must be diagnosed with single stone burden \<2.0 cm
  3. 3. Patients must opt for definitive treatment with ureteroscopy with lase lithotripsy and stone basket extraction
  1. 1. Patients with multiple stones or stones bilaterally
  2. 2. Patient with stones \>2.0cm
  3. 3. Patient who wish to continue with trial of passage

Contacts and Locations

Study Contact

Jane Ledesma
CONTACT
19135888721
jledesma2@kumc.edu
Cary Felzien
CONTACT
19135886142
cfelzien@kumc.edu

Principal Investigator

Wilson Molina, MD
PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center

Study Locations (Sites)

University of Kansas Medical Center
Kansas City, Kansas, 66160
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

  • Wilson Molina, MD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-01
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2022-09-01
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Kidney Stone